Literature DB >> 1385477

Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and murine interleukin-3.

K Kaushansky1, S G Shoemaker, V C Broudy, N L Lin, J V Matous, E M Alderman, J D Aghajanian, P J Szklut, R E VanDyke, M K Pearce.   

Abstract

IL-3 is a glycoprotein cytokine involved in the hematopoietic response to infectious, immunologic, and inflammatory stimuli. In addition, clinical administration of recombinant IL-3 augments recovery in states of natural and treatment-related marrow failure. IL-3 acts by binding to high affinity cell surface receptors present on hematopoietic cells. To determine the site(s) at which IL-3 binds to it receptor, we analyzed a series of interspecies chimera of the growth factor for species-specific receptor binding and biological activity. The results suggest that IL-3 binds to its receptor and triggers a proliferative stimulus through two noncontiguous helical domains located near the amino terminus and the carboxy terminus of the molecule. To corroborate these findings, we have also mapped the binding epitopes of 10 mAb of human or murine IL-3, and have defined four distinct epitopes. Two of these epitopes comprise the amino-terminal receptor binding domain. A third epitope corresponds to the carboxy-terminal receptor interactive domain, and the fourth epitope, apparently not involved in the interaction of IL-3 and its receptor, lies between these sites. And on the basis of sandwich immunoassays using pairs of these mAbs, the two receptor interactive regions appear to reside in close juxtaposition in the tertiary structure of the molecule. These results provide a correlation of the structure-function relationships of IL-3 that should prove useful in evaluating the details of IL-3-IL-3 receptor interaction and in the rational design of clinically useful derivatives of this growth factor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385477      PMCID: PMC443249          DOI: 10.1172/JCI116065

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Structural design and molecular evolution of a cytokine receptor superfamily.

Authors:  J F Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  Effects of human interleukin-3 on granulocytic colony-forming cells in human bone marrow.

Authors:  F J Bot; L van Eijk; P Schipper; B Löwenberg
Journal:  Blood       Date:  1989-04       Impact factor: 22.113

3.  Conformational homologies among cytokines: interleukins and colony stimulating factors.

Authors:  D A Parry; E Minasian; S J Leach
Journal:  J Mol Recognit       Date:  1988-06       Impact factor: 2.137

4.  Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils.

Authors:  A F Lopez; J M Eglinton; D Gillis; L S Park; S Clark; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

5.  Analysis of human IL-6 mutants expressed in Escherichia coli. Biologic activities are not affected by deletion of amino acids 1-28.

Authors:  J P Brakenhoff; M Hart; L A Aarden
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

6.  IL-3 specifically inhibits GM-CSF binding to the higher affinity receptor.

Authors:  F Taketazu; S Chiba; K Shibuya; T Kuwaki; H Tsumura; K Miyazono; K Miyagawa; F Takaku
Journal:  J Cell Physiol       Date:  1991-02       Impact factor: 6.384

7.  Hematopoietic activity of granulocyte/macrophage colony-stimulating factor is dependent upon two distinct regions of the molecule: functional analysis based upon the activities of interspecies hybrid growth factors.

Authors:  K Kaushansky; S G Shoemaker; S Alfaro; C Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

8.  Antipeptide antibodies define the NH2-terminal structure of the pan-specific hemopoietin interleukin 3.

Authors:  H J Ziltener; I Clark-Lewis; B Fazekas de St Groth; L E Hood; S B Kent; J W Schrader
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

9.  Establishment of strongly neutralizing monoclonal antibody to human interleukin-6 and its epitope analysis.

Authors:  N Ida; S Sakurai; T Hosaka; K Hosoi; T Kunitomo; T Shimazu; T Maruyama; Y Matsuura; M Kohase
Journal:  Biochem Biophys Res Commun       Date:  1989-12-15       Impact factor: 3.575

10.  Interleukin-3 is significantly more effective than other colony-stimulating factors in long-term maintenance of human bone marrow-derived colony-forming cells in vitro.

Authors:  M Kobayashi; B H Van Leeuwen; S Elsbury; M E Martinson; I G Young; A J Hapel
Journal:  Blood       Date:  1989-05-15       Impact factor: 22.113

View more
  3 in total

1.  Molecular evolution of interleukin-3.

Authors:  H Burger; G Wagemaker; J A Leunissen; L C Dorssers
Journal:  J Mol Evol       Date:  1994-09       Impact factor: 2.395

2.  Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy.

Authors:  K Kaushansky; V C Broudy; A Grossmann; J Humes; N Lin; H P Ren; M C Bailey; T Papayannopoulou; J W Forstrom; K H Sprugel
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

3.  A cytokine-cytokine interaction in the assembly of higher-order structure and activation of the interleukine-3:receptor complex.

Authors:  Raja Dey; Kunmei Ji; Zhigang Liu; Lin Chen
Journal:  PLoS One       Date:  2009-04-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.